Tech Company Acquirers
Nabriva Therapeutics
Researching who was bought by Nabriva Therapeutics? Zavante Therapeutics did a deal with this biopharmaceutical company.
Company Overview
Company Name
Nabriva Therapeutics
Company Status
Publicly-held
Industry
Biopharmaceutical
Acquisitions
Contact Information
Mailing Address
1000 Continental Dr. 600
King of Prussia, PA 19406
USA
King of Prussia, PA 19406
USA
Phone
Website
Email Address
Company Background Information
Overview
Nabriva Therapeutics (Nasdaq: NBRV) is a biotechnology company focused on developing a new class of antibiotics, pleuromutilins, for the treatment of patients with serious infections caused by multi-drug resistant pathogens.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/25/2018
Acquisitions By Nabriva Therapeutics
Date
Company
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Colin Broom
Chief Financial Officer
Gary Sender
Chief Medical Officer
Jennifer Schranz
VP - Bus. Development
Steven Gelone
VP - General Counsel
Robert Crotty
Browse more tech company acquirers:
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs